You are here

drug pricing

The ability to pivot will be ‘key’ as pharma’s tariff threat looms

Pharma Voice

Mon, 01/13/25 - 11:16 am

Fueled by new launches, US drug prices poised to continue trending upward: Cowen report

Fierce Pharma

Fri, 01/10/25 - 11:41 am

Some pharmaceutical mergers lower drug prices: Study

Beckers Hospital Review

Thu, 01/9/25 - 09:15 pm

Drug price talks provide an early test for Trump

Axios

Thu, 01/9/25 - 11:07 am

Trump tariffs and drug prices: 3 notes

Beckers Hospital Review

Thu, 01/2/25 - 11:16 am

Drugmakers plan price hikes for 250+ medications in 2025

Beckers Hospital Review

Wed, 01/1/25 - 10:31 pm

Bristol Myers Squibb

ICER identifies new crop of 'unsupported' drug price rises

Pharmaphorum

Fri, 12/13/24 - 11:30 am

ICER calls out Gilead, J&J, Novartis and more in latest report on 'unsupported' price increases

Fierce Pharma

Thu, 12/12/24 - 11:44 pm

Gilead Sciences

Novo Nordisk slashes prices of additional insulin products but not until 2026

Fierce Pharma

Sun, 12/8/24 - 09:42 pm

Novo Nordisk to cut US list prices of two insulin products by more than 70%

MSN/Reuters

Thu, 12/5/24 - 04:14 pm

Four Revelations from Minnesota’s First 340B Transparency Report

Drug Channels

Tue, 12/3/24 - 11:27 am

Big pharma pushes Trump team to ease Medicare drug price negotiation rules

MSN/Reuters

Wed, 11/27/24 - 10:02 pm

Trump tariffs could drive up generic drug costs: 5 takeaways

Beckers Hospital Review

Tue, 11/26/24 - 11:13 am

Future of Medicare drug price negotiations under new administration: 5 things to know

Beckers Hospital Review

Tue, 11/19/24 - 10:59 am

Inflation Reduction Act

Election 2024: Where do Harris and Trump stand on health policy?

Fierce Healthcare

Tue, 11/5/24 - 11:23 am

2020 Presidential election

healthcare reform

Pharmas ask appeals court to reconsider IRA lawsuits

Pharmaphorum

Mon, 11/4/24 - 11:08 am

Inflation Reduction Act

Bristol Myers Squibb

Drug pricing and the 2024 presidential election

Fierce Pharma

Fri, 11/1/24 - 11:00 am

2024 Presidential election

The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions

Drug Channels

Tue, 10/22/24 - 11:28 pm

Inflation Reduction Act proves positive boost for biosimilars

Pharmaphorum

Thu, 10/10/24 - 09:49 am

Inflation Reduction Act

US releases preliminary list of $2 generic drugs for Medicare recipients

Reuters

Wed, 10/9/24 - 11:15 am

Pages